NewEdge Advisors LLC lessened its position in shares of Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report) by 16.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 96,918 shares of the company’s stock after selling 18,492 shares during the quarter. NewEdge Advisors LLC owned approximately 1.05% of Columbia Research Enhanced Value ETF worth $2,774,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of REVS. MML Investors Services LLC acquired a new position in shares of Columbia Research Enhanced Value ETF in the fourth quarter valued at $32,212,000. LPL Financial LLC boosted its stake in Columbia Research Enhanced Value ETF by 24.6% during the fourth quarter. LPL Financial LLC now owns 2,249,697 shares of the company’s stock worth $63,628,000 after buying an additional 443,608 shares in the last quarter. Raymond James Financial Inc. increased its holdings in Columbia Research Enhanced Value ETF by 396.4% in the 2nd quarter. Raymond James Financial Inc. now owns 200,098 shares of the company’s stock valued at $5,259,000 after buying an additional 159,786 shares during the period. First Interstate Bank bought a new stake in Columbia Research Enhanced Value ETF in the 1st quarter valued at $1,321,000. Finally, World Investment Advisors acquired a new position in shares of Columbia Research Enhanced Value ETF in the 4th quarter valued at $1,169,000.
Columbia Research Enhanced Value ETF Stock Performance
Shares of REVS stock opened at $34.00 on Friday. The firm has a fifty day moving average of $32.48 and a 200-day moving average of $30.76. The stock has a market cap of $340 million, a price-to-earnings ratio of 16.41 and a beta of 0.79. Columbia Research Enhanced Value ETF has a 52-week low of $27.13 and a 52-week high of $34.03.
Columbia Research Enhanced Value ETF Profile
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
See Also
- Five stocks we like better than Columbia Research Enhanced Value ETF
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Want to see what other hedge funds are holding REVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
